Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF AUGUST 04, 2017 FBO #5733
MODIFICATION

A -- Surveillance for Emerging Viral Respiratory Pathogens in South America

Notice Date
8/2/2017
 
Notice Type
Modification/Amendment
 
NAICS
541712 — Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
 
Contracting Office
Department of the Navy, Bureau of Medicine and Surgery, U.S. Naval Medical Research Unit - 6 Peru, Unit 3230 Box 343, American Embassy, DPO AA 34031-0343, Lima, Non-U.S., 34031-0343, Peru
 
ZIP Code
00000
 
Solicitation Number
N4485217RCP0106
 
Archive Date
8/22/2017
 
Point of Contact
Thomas Hood, , Karl Molina,
 
E-Mail Address
thomas.l.hood26.civ@mail.mil, karl.o.molina.civ@mail.mil
(thomas.l.hood26.civ@mail.mil, karl.o.molina.civ@mail.mil)
 
Small Business Set-Aside
N/A
 
Description
The Naval Medical Logistics Command (NMLC) is seeking sources for research and development support services in support of a viral febrile and respiratory surveillance study. The Government's requirement is for research support from a capable institution with a large trajectory of research in infectious and tropical diseases, mainly in viruses for a collaborative research effort to execute in Peru the studies entitled: "Characterization of the infectious causes of acute febrile illness in Latin America" and "Surveillance for Emerging Viral Respiratory Pathogens in South America". This study is aimed at determining the etiology of febrile and respiratory disease syndromes in a number of countries throughout Latin America (Peru, Colombia, Honduras and Paraguay) including ten cities in Peru (Lima, Callao, Piura, Bagua, Yurimaguas, Trujillo, La Merced, Cusco, Chanchamayo and Iquitos). This effort requires carrying out coordination and obtainment of study authorization from local health facilities to perform the study; obtainment of local IRB approval; recruitment of and training local heath personnel for performing the study; screening at least 300 potential study participants per year per site; performing the informed consent process as described in the protocol; collecting all the study approved information and biological samples (oropharyngeal swabs, total blood and serum); labeling and keeping of samples in adequate cold-chain conditions to preserve viruses; maintenance of all forms with identifiers in a locked office inside the site; preparation of biological samples for shipments to NAMRU-6 in adequate cold-chain conditions; shipment of samples in proper cold-chain conditions to NAMRU-6; delivery to NAMRU-6 of all samples collected as part of the study, consent/assent documents, and all epidemiological forms; reporting laboratory results provided by NAMRU-6 to local health authorities. All activities must be carried out with the utmost adherence to all ethical and quality standards in order to minimize risk of performance slips and comply with appropriation of funds and expectations of the sponsor. The period of performance is expected to be 12 months from the date of contract approval. If capable sources are not identified through this notice, then NMLC intends to award a sole source contract under the authority of FAR 6.302-1 (One source) to Universidad Peruana Cayetano Heredia (UPCH) in Peru, for the performance of the described requirement. Universidad Peruana Cayetano Heredia (UPCH) is the only source able to meet our research needs for both Peru and the greater Latina American region. UPCH has a large trajectory of research in infectious and tropical diseases, mainly in viruses. This institution is the only one with the required local approvals in place, the appropriate financial, human and technical resources, experience and organizational controls needed to accomplish the study's goals. This sources sought notice is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Capability statements shall not exceed 5 (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source contract. Capability statements are due by 2:00 PM Local Time, 07, August 2017. Capability statements shall be submitted by e-mail ONLY as a Microsoft Word or Adobe PDF attachment to the following address: thomas.l.hood26.civ@mail.mil.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/notices/0326dd9f99a6a62afbf613b1b6a3eafb)
 
Place of Performance
Address: Venezuela Ave. Block 36 Bellavista-Callao, Lima, Peru
 
Record
SN04608923-W 20170804/170802232059-0326dd9f99a6a62afbf613b1b6a3eafb (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.